Generex Biotechnology Corporation (Nasdaq:GNBT) announced today that it has received new patents in Canada and Argentina. The Canadian Intellectual Property Office has granted the Company a new patent titled, "Mixed Micellar Pharmaceutical Delivery System and Method of Preparation." The patent contains process, formulation and use claims to a mixed micellar pharmaceutical formulation for buccal administration.
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, has received allowance of a second US patent application protecting a novel photoactive analog of its lead photodynamic product PH-10, from the United States Patent and Trademark Office (USPTO). The pending patent covers systemic use of the drug, PH-12, for photodynamic treatment of cancer, skin diseases, and other tissue disorders using visible light activation.
No comments:
Post a Comment